Results 291 to 300 of about 257,683 (336)
Correction to: Management of adult patients with podocytopathies: an update from the ERA Immunonephrology Working Group. [PDF]
Nephrol Dial Transplanteuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Cyclophosphamide in dermatology
Australasian Journal of Dermatology, 2016AbstractCyclophosphamide is a chemotherapeutic agent which was first discovered in experimental tumours in rats, and it has since been widely used to treat malignancies and severe manifestations of various auto‐immune diseases. High‐dose chemotherapy and continuous daily oral regimens are associated with significant toxicity profiles, but i.v.
Janet Kim, Jonathan Chan
openaire +4 more sources
Immunopharmacology and immunotoxicology, 2021
Aim: Major side effects of cyclophosphamide administration are immunosuppression and myelosuppression. The immunomodulatory effects of plant bioactive compounds on chemotherapy drug-induced immunosuppression may have significant effects in cancer ...
M. Berköz +12 more
semanticscholar +1 more source
Aim: Major side effects of cyclophosphamide administration are immunosuppression and myelosuppression. The immunomodulatory effects of plant bioactive compounds on chemotherapy drug-induced immunosuppression may have significant effects in cancer ...
M. Berköz +12 more
semanticscholar +1 more source
Cancer Chemotherapy and Pharmacology, 1981
Little information is available about the effect of cytotoxic drugs on diabetes mellitus. Cyclophosphamide has been reported to be a possible cause of mild diabetes [2], but Kruger [1] described two diabetics whose blood sugar levels fell during treatment with cyclophosphamide.
R. G. Henderson, Robert D. Rubens
openaire +3 more sources
Little information is available about the effect of cytotoxic drugs on diabetes mellitus. Cyclophosphamide has been reported to be a possible cause of mild diabetes [2], but Kruger [1] described two diabetics whose blood sugar levels fell during treatment with cyclophosphamide.
R. G. Henderson, Robert D. Rubens
openaire +3 more sources
Journal of Pharmaceutical Sciences, 1972
A GLC procedure was developed for the assay of cyclophosphamide raw materials and cyclophosphamide in formulations. Results obtained by this technique are comparable to those obtained by IR spectroscopy. The GLC procedure offers increased accuracy, reproducibility, and precision. The method is more specific and less time consuming than the IR procedure.
C.M. Combs +4 more
openaire +3 more sources
A GLC procedure was developed for the assay of cyclophosphamide raw materials and cyclophosphamide in formulations. Results obtained by this technique are comparable to those obtained by IR spectroscopy. The GLC procedure offers increased accuracy, reproducibility, and precision. The method is more specific and less time consuming than the IR procedure.
C.M. Combs +4 more
openaire +3 more sources
Cyclophosphamide cardiotoxicity
European Journal of Pediatrics, 1980A 12-year-old boy with aplastic anemia developed severe but reversible cardiac failure after treatment with 200 mg/kg cyclophosphamide (4 x 50 mg/kg on four consecutive days) given as preparation for bone marrow grafting. This and previously reported cases demonstrate the possibility of cardiotoxicity after high doses of the drug.
G, von Bernuth +6 more
openaire +2 more sources
Novel class of cyclophosphamide prodrug: Cyclophosphamide spiropiperaziniums (CPSP)
Bioorganic & Medicinal Chemistry Letters, 2006AbstractChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 200 leading journals. To access a ChemInform Abstract, please click on HTML or PDF.
Qi Sun +5 more
openaire +4 more sources